Acumed Acquires ExsoMed to Expand Upper Extremity Device Portfolio
July 6, 2022
Acumed, a Colson Medical | Marmon | Berkshire Hathaway company, has acquired ExsoMed, a developer of minimally invasive intramedullary fixation devices for hand surgery. The acquisition adds ExsoMed’s threaded nails and related products to Acumed’s portfolio to broaden its minimally invasive and upper-extremity treatment offerings.
- Buyers
- Acumed
- Targets
- ExsoMed
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Arterex (Investindustrial-backed) Acquires NextPhase Medical Devices
July 17, 2023
Medical Devices
Arterex (Medical Device, Inc.), an Investindustrial-backed medical device contract manufacturer, has acquired NextPhase Medical Devices from Kidd & Company, LLC. The deal expands Arterex’s global multi-capability platform — nearly doubling the group’s scale and adding complementary design, engineering and complex electromechanical and implantable device manufacturing capabilities across North America and internationally.
-
Exo Acquires Medo AI to Bring AI-Enabled Ultrasound Imaging to Point-of-Care
July 26, 2022
Medical Devices
Exo announced it is acquiring Medo, a Canadian developer of AI technology used for ultrasound imaging. By integrating Medo’s proprietary Sweep AI into Exo’s ultrasound platform, Exo aims to make ultrasound imaging faster and easier for a broader range of caregivers and accelerate adoption of point-of-care ultrasound.
-
DePuy Synthes (Johnson & Johnson) Acquires CrossRoads Extremity Systems from HealthpointCapital
February 10, 2022
Medical Devices
DePuy Synthes, the orthopaedics business of Johnson & Johnson, has acquired CrossRoads Extremity Systems, a Memphis-based designer and manufacturer of procedure-specific implants and instruments for foot and ankle surgery. The seller was HealthpointCapital (with long-time investor MB Venture Partners involved); HealthpointCapital had acquired a majority stake in CrossRoads in May 2019 and executed product and commercial expansion before the sale.
-
Exactech Acquires Minority Stake in JointMedica
January 24, 2022
Medical Devices
Exactech, Inc. acquired a minority interest in U.K.-based JointMedica Limited to collaborate on commercialization of the Polymotion hip resurfacing implant. The partnership pairs JointMedica's device design and manufacturing capabilities with Exactech's global distribution and clinical relationships to bring the next generation of hip resurfacing to targeted markets following regulatory approvals.
-
HealthpointCapital Acquires Controlling Stake in CrossRoads Extremity Systems
May 14, 2019
Medical Devices
HealthpointCapital has acquired a controlling (majority) stake in CrossRoads Extremity Systems, a Memphis-based developer and manufacturer of foot & ankle implants, procedure-specific sterile-packed instrumentation, and the EcoSMART instrument recovery service. HealthpointCapital will partner with CrossRoads' co-founders and management, providing additional equity to fund organic growth, expand the company's portfolio and market presence, and pursue bolt-on acquisitions.
-
Boston Scientific Acquires Xlumena
April 1, 2015
Medical Devices
Boston Scientific agreed to acquire Mountain View–based medical device company Xlumena, gaining the AXIOS and HOT AXIOS stent and delivery systems. The deal includes $62.5 million upfront, $12.5 million contingent on FDA clearance of HOT AXIOS and additional sales-based milestones, and is intended to expand Boston Scientific's endoscopy and EUS therapeutic capabilities and accelerate global commercialization of the AXIOS platform.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.